SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
Clinical trial NCT06611137 · RECRUITING
Trial details
- NCT number
- NCT06611137
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-11
- Primary completion
- 2025-09-11
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.